If you are a doctor, nurse or pharmacist involved in the care of patients with depression, you may like to take this self-directed learning module on selective serotonin reuptake inhibitors (SSRI) antidepressants produced by the Medicines and Healthcare products Regulatory Agency (MHRA).
The free online training outlines the key risks of this important class of medicines. For each adverse effect, the package outlines:
- The main features of the adverse effect
- Factors that increase the risk
- How the risk can be reduced
- Specific treatment for the adverse effect
A self-assessment exercise, together with full feedback, complements the learning material.
MHRA say that clinicians starting out in psychiatry will find it especially valuable.
SSRI learning module. Medicines and Healthcare products Regulatory Agency, 24 Nov 2011.
Read through the whole “advice” and you will find that the MHRA have been lying. Pay particular attention to the ‘withdrawal’ section.